Tandem Diabetes Care director acquires 6,747 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tandem Diabetes Care (TNDM) director Sandra Beaver had 6,747 restricted stock units vest on November 15, 2026, corresponding to her acquisition of 6,747 common shares. After the transactions, she directly held 6,747 common shares and 13,495 restricted stock units. The RSUs were awarded November 7, 2025, under the company’s 2023 Long-Term Incentive Plan; one-third vested on November 15, 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2, F3 | 6,747 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,747 | $0.00 | $0.00 |
Footnotes (3)
- F1. Awarded on November 7, 2025 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- F2. Each Restricted Stock Unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- F3. One-third of the RSUs granted on November 7, 2025 vested on November 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
Key Figures
Key Terms
Restricted Stock Unit (RSU) financial
2023 Long-Term Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the vesting terms for Sandra Beaver’s Tandem Diabetes Care RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.